Ticker LaunchReverse merger · Completed
Nanomix, Inc.
Reverse merger with Boston Therapeutics, Inc.
Nanomix, Inc. merged into Boston Therapeutics, Inc., a public pharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Jan 26, 2021 and closed on Jun 10, 2021. The combined company trades as Nanomix Corporation.
- Status
- Completed
- Private company
- Nanomix, Inc.
- Public company
- Boston Therapeutics, Inc.
- Public company business before
- public pharmaceutical company
- Announced
- Jan 26, 2021
- Closed
- Jun 10, 2021
- Combined company
- Nanomix Corporation
- Sector
- Medical devices
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (completion of acquisition) Jun 10, 2021
- Form 8-K (merger agreement) Feb 2, 2021
- All filings on EDGAR CIK 1473579
Other completed reverse mergers
- HotPlay Enterprise Limitedinto Monaker Group, Inc. · Jun 30, 2021
- Metamaterial Inc.into Torchlight Energy Resources, Inc. · Jun 28, 2021
- Biond Photonics, Inc.into Parc Investments, Inc. · Jun 22, 2021
- ABTI Pharma Limitedinto Alterola Biotech Inc. · Jun 16, 2021
- Kun Peng International Holding Limitedinto CX Network Group, Inc. · May 17, 2021
- Leading BioSciences, Inc.into Seneca Biopharma, Inc. · Apr 27, 2021